Table 3. Univariate regression analyses of patient characteristics with respect to PFS.
Patient characteristics | HR | 95% CI | P | Cutoff (≥) | HR (of > cutoff) | 95% CI | P |
---|---|---|---|---|---|---|---|
TP2 NLR | 1.018 | 1-1.035 | 0.0456 | 36 | 3.56 | 1.61-7.88 | 0.0008 |
TP2 PLR | 1.0005 | 1-1.001 | 0.02297 | 429.7 | 2.55 | 1.12-5.81 | 0.021 |
TP3 NLR | 0.9987 | 0.9666-1.032 | 0.9365 | 6.278 | 0.48 | 0.25-0.96 | 0.033 |
TP3 PLR | 0.9996 | 0.99984-1.001 | 0.5511 | 245.3 | 0.39 | 0.17-0.91 | 0.023 |
Distal | 0.4178 | 0.1822-0.9584 | 0.0394 | NA | NA | NA-NA | NA |
PFS, progression free survival; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; NA, not available.